[PUBLICATION] Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model

Alzheimer Disease
Alzheimer Disease

from January 12, 2022 to January 19, 2022

Collaborative research project led by Prof. Page (EA3808 Neurovascular Unit and Cognitive Disorders, University of Poitiers, Poitiers, France) in which Drs. Chalon, Galineau, Tauber and Serrière participated.

 / 1
Contact :
Dr. Sylvie Chalon :